Financial Summary (All financials)
| In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 |
| Revenues | 60,535.0 | 63,155.0 | 60,337.0 | 58,003.0 | 47,294.6 | 36,599.8 | 33,782.2 | 34,246.0 |
| Revenue growth | -4.1% | 4.7% | 4.0% | 22.6% | 29.2% | 8.3% | -1.4% | -1.5% |
| Cost of goods sold | 33,143.0 | 34,747.0 | 32,558.0 | 32,594.0 | 4,139.5 | 3,115.3 | 3,284.3 | 3,076.4 |
| Gross profit | 27,392.0 | 28,408.0 | 27,779.0 | 25,409.0 | 43,155.1 | 33,484.5 | 30,497.9 | 31,169.6 |
| Gross margin | 45.2% | 45.0% | 46.0% | 43.8% | 91.2% | 91.5% | 90.3% | 91.0% |
| Selling, general and administrative | | | | | | | | |
| Sales and marketing | 1,598.0 | 1,678.0 | 1,611.0 | 1,653.0 | 1,348.6 | 1,105.5 | 1,104.8 | 1,226.6 |
| General and administrative | 10,466.0 | 10,407.0 | 10,033.0 | 9,180.0 | 7,296.8 | 5,770.9 | 5,699.6 | 5,292.4 |
| EBITA | 3,691.0 | 4,958.0 | 4,859.0 | 4,173.0 | 3,461.0 | 2,923.5 | 3,268.5 | 2,890.5 |
| EBITA margin | 6.1% | 7.9% | 8.1% | 7.2% | 7.3% | 8.0% | 9.7% | 8.4% |
| Amortization of intangibles | 272.0 | 247.0 | 255.0 | 243.0 | 214.6 | 142.0 | 120.7 | 95.2 |
| EBIT | 3,419.0 | 4,711.0 | 4,604.0 | 3,930.0 | 3,246.4 | 2,781.5 | 3,147.8 | 2,795.3 |
| EBIT margin | 5.6% | 7.5% | 7.6% | 6.8% | 6.9% | 7.6% | 9.3% | 8.2% |
| Pre-tax income | 2,992.0 | 3,991.0 | 4,236.0 | 3,500.0 | 2,940.5 | 2,547.3 | 3,079.0 | 2,644.2 |
| Income taxes | 1,087.0 | 1,735.0 | 1,841.0 | 1,455.0 | 1,028.6 | 887.5 | 1,092.1 | 877.4 |
| Tax rate | 36.3% | 43.5% | 43.5% | 41.6% | 35.0% | 34.8% | 35.5% | 33.2% |
| Net income | 1,904.0 | 2,271.0 | 2,390.0 | 2,041.0 | 1,913.6 | 1,657.9 | 1,985.7 | 1,766.8 |
| Net margin | 3.1% | 3.6% | 4.0% | 3.5% | 4.0% | 4.5% | 5.9% | 5.2% |
| |
| Diluted EPS | $5.68 | $6.41 | $6.78 | $5.68 | $5.33 | $4.81 | $5.22 | $4.18 |
| Shares outstanding (diluted) | 335.4 | 354.3 | 352.6 | 359.1 | 359.2 | 345.0 | 380.2 | 422.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|